Search alternatives:
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
μ decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
cs decrease » a decrease (Expand Search), c decreased (Expand Search), we decrease (Expand Search)
50 nn » 50 ns (Expand Search), 50 ng (Expand Search), 50 n (Expand Search)
50 cs » 50 cas (Expand Search), 50 c (Expand Search), 50 ms (Expand Search)
nn decrease » a decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
μ decrease » a decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
cs decrease » a decrease (Expand Search), c decreased (Expand Search), we decrease (Expand Search)
50 nn » 50 ns (Expand Search), 50 ng (Expand Search), 50 n (Expand Search)
50 cs » 50 cas (Expand Search), 50 c (Expand Search), 50 ms (Expand Search)
-
1
-
2
Scatter plot for the absolute decrease in CS rates (A) and the relative decrease in CS rates (B) from 2008 to 2016 among hospitals in Guangzhou grouped by their baseline CS rates.
Published 2019“…The absolute decrease = the CS rate at baseline − the CS rate in Stage 2; the relative decrease = (the CS rate at baseline − the CS rate in Stage 2) ÷ the CS rate at baseline. …”
-
3
-
4
-
5
-
6
-
7
-
8
-
9
mGluR5 receptor decreased glycinergic currents.
Published 2019“…(<b>E</b>) The inhibitory effect of CHPG on GlyR-IPSCs was not blocked by intracellularly loaded GDP-β-S (62.3 ± 6.4% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.782, <i>p</i> = 0.032), chelerythrine (60.9 ± 11.3% of baseline at 15–20 min post-CHPG, <i>t</i>[6] = 2.705, <i>p</i> = 0.035), or Ro-32-0432 (69.9 ± 3.2% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 8.495, <i>p</i> < 0.001). (<b>F</b>) Postsynaptic loading of U-0126 or PD98059 prevented CHPG from decreasing glycinergic responses (U-0126, 107.6 ± 10.4% of baseline at 15–20 min post-CHPG, <i>t</i>[8] = 0.997, <i>p</i> = 0.348; PD98059, 93.1 ± 5.0% of baseline at 15–20 min post-CHPG, <i>t</i>[5] = 0.883, <i>p</i> = 0.418). …”
-
10
-
11
-
12
Results of sequentially rejective Bonferroni procedure for CS, BO, and STS.
Published 2024Subjects: -
13
ABT199 inhibits ALK <sup>mutant</sup> kinase activity and decreases it phosphorylation.
Published 2025Subjects: -
14
-
15
-
16
-
17
-
18
-
19
-
20
GSK343 decreased tumor stemness.
Published 2021“…<p>(A) COA3 and (B) COA6 PDX cells were plated as single cell suspension in serum-free, conditioned media onto 96-well low attachment plates using serial dilutions with 5000, 1000, 100, 50, 20, 10, and 1 cell per well. Cells were treated with GSK343 (0, 5 μM). …”